This new 249-page report provides a comprehensive analysis of the US therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
Request a Copy of this Report @ http://www.reportsnreports.com/contacts/requestsample.aspx?name=274309 .
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
“2014 Strategies for the US Therapeutic Drug Monitoring (TDM) Market” is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Complete report is available @ http://www.reportsnreports.com/reports/274309-2014-strategies-for-the-us-therapeutic-drug-monitoring-tdm-market.html .
Table of Contents
Worldwide Market and Technology Overview
A. Major Therapeutic Drug Monitoring Tests
18. Valproic Acid
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC Analyzers manufactured by Abaxis, Abbott, Alere/Inverness, Alfa Wassermann, AMS, Awareness Technologies, Beckman Coulter/Olympus, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Grifols, Horiba, Medica, Nova Biomedical, Ortho-Clinical Diagnostics, Polymedco, Randox, Roche, Siemens, Tosoh, Vital Diagnostics and other Suppliers
C. Major In VitrDiagnostic Technologies and Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
a. Technological Principle
c. Enzyme Immunoassays (EIA)
d. Radioimmunoassays (RIA)
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
D. Market Size, Growth and Major Supplier Shares
Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
- Abbott Laboratories - AdnaGen
- Agilent Technologies
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- Instrumentation Laboratory
- Kyowa Medex
- Ortho-Clinical Diagnostics
- Quest Diagnostics
Inquire for Discount on this Report @ http://www.reportsnreports.com/contacts/discount.aspx?name=274309 .
List of Tables
Companies Developing or Marketing TDM Tests
Major Companies Developing or Marketing Digoxin Tests
Major Companies Developing or Marketing Lithium Tests
Major Companies Developing or Marketing Phenytoin Tests
Major Companies Developing or Marketing Theophylline Tests
Major Companies Developing or Marketing Valproic Tests
Major Companies Developing or Marketing Biosensors for Genetic Disease Testing
U.S.A., Laboratories Performing TDM Tests By Market Segment
U.S.A., Hospital Laboratories Performing TDM Tests By Bed Size
U.S.A., Commercial/Private Laboratories Performing TDM Tests By Annual Test Volume
U.S.A., TDM Test Volume Forecast By Market Segment
U.S.A., Hospital Laboratories, TDM Test Volume Forecast by Assay
U.S.A., Commercial/Private Laboratories, TDM Test Volume Forecast by Assay
U.S.A., Physician Offices/Group Practices, TDM Test Volume Forecast by Assay
U.S.A., TDM Reagent Market Forecast By Market Segment
U.S.A., Hospital Laboratories, TDM Reagent Market Forecast by Assay
U.S.A., Commercial/Private Laboratories, TDM Reagent Market Forecast by Assay
U.S.A., Physician Office/Group Practices, TDM Reagent Market Forecast by Assay
U.S.A., Major Suppliers of Immunodiagnostic Products, Estimated Market Shares
Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx?name=274309 .
Contactsales@reportsandreports.com/ Call +1 888 391 5441 for further information on “2014 Strategies for the US Therapeutic Drug Monitoring (TDM) Market” report OR for any other market research and intelligence needs you may have for your business.